Keratoconjunctivitis Sicca

·MeSH: Keratoconjunctivitis Sicca

7 drugs in development·5 companies·3 clinical trials

Drug Pipeline by Phase

Approved(2)

Drug	Company
cyclosporine	Amneal Pharmaceuticals, Inc. (AMRX)
cyclosporine	Mylan II B.V. (MYL)

Phase 3(5)

Drug	Company
pl9643	PALATIN TECHNOLOGIES INC (PTN)
rebamipide 1%	West Pharmaceutical Services Inc. (WST)
rebamipide 1%	NYMOX PHARMACEUTICAL CORP (NYMXF)
rebamipide 2%	NYMOX PHARMACEUTICAL CORP (NYMXF)
rebamipide 2%	West Pharmaceutical Services Inc. (WST)

BioSniper tracks 7 drugs in development for Keratoconjunctivitis Sicca across 5 companies.

There are 3 clinical trials targeting Keratoconjunctivitis Sicca tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.